Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion Barrier

NCT ID: NCT02165917

Last Updated: 2015-11-03

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: PHASE4
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2015-05-31
• Study Completion Date: 2017-05-31

Brief Summary

Endometriosis is a common disease of women in the reproductive age and is an important cause for female infertility. Endometriosis is often associated with the development of adhesions which further compromises the fertility of the affected women. The main purpose of this study is to investigate the pregnancy rate one year after excision of endometriosis and application of GnRH-analogues (Gonadotropin-releasing hormone) for 3 month. Half of the patients will receive traditional endometriosis treatment with the excision of the endometriotic lesions only. The other half will additionally receive a gel which can reduce adhesion formation (Hyalobarrier®). Further study objective is the investigation in the development of different types of endometriosis-associated pain over a period of one year. Potential study participants are women with endometriosis-associated pain and with a desire to have children. It will be investigated in the study if the use of Hyalobarrier® will result in a higher pregnancy rate due to reduced adhesion development.

Detailed Description

Design: Prospective, monocentric, comparative, randomized, semi-blind.

There will be 30 subjects in each arm, who will be followed 15 months after surgery.

Half of the patients will receive standard laparoscopic excision of the endometriotic lesions only. The other half, after the excision of the endometriosis foci, will receive 10 cc of an antiadhesion agent which contents hyaluronic acid gel (Hyalobarrier®).The subjects will be hospitalized after surgery for at least 2 days.

A Vas-Scala will be given to the subjects to estimate the pain before, after surgery and one year after treatment. The participants will record the values each three months after surgery.

All subjects will be asked by telephone for the VAS-scala values and for pregnancy (Date of Initiation, clinical evolution)

The participation ist voluntary and an Informed consent must be signed before surgery. Subjects are free to withdraw their consent anytime.

Conditions

Endometriosis

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Excision only

Laparoscopic excision of endometriotic lesions followed by 3 month of GnRH-Analogue administration

Group Type: PLACEBO_COMPARATOR

Excision only

Intervention Type: PROCEDURE

Excision of endometriosis foci by laparoscopic standard methods only.

Excision plus hyaluronic acid gel

Standard Laparoscopic excision of endometriotic lesions plus application of 10 cc of a hyaluronic acid gel (Hyalobarrier® ), followed by 3 month of GnRH-analogue administration

Group Type: ACTIVE_COMPARATOR

Excision plus hyaluronic acid gel

Intervention Type: PROCEDURE

Excision of endometriosis foci by laparoscopic standard methods followed by an application of 10 cc Hyaluronic acid gel, in order to prevent postsurgical adhesions.

Interventions

Excision plus hyaluronic acid gel

Excision of endometriosis foci by laparoscopic standard methods followed by an application of 10 cc Hyaluronic acid gel, in order to prevent postsurgical adhesions.

Intervention Type: PROCEDURE

Excision only

Excision of endometriosis foci by laparoscopic standard methods only.

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Women over 18 years with endometriosis-associated pain, like dysmenorrhea, dyspareunia, lower abdominal pain, low-back pain, rectal pain, defecation pain (only one criterion needs to be fulfilled for study inclusion);
• Participants are in good general health except for endometriosis related problems;
• Except for endometriosis, no existence of an obvious diseases which could cause chronic pain or which could cause abdominal pain;
• The participant must have a desire to have children;
• Participants must be able to give their consent and must understand the risks associated with a participation in the study;
• There must be a signed and dated informed consent which was accepted by the local ethic committee

Exclusion Criteria

• Existent pregnancy including ectopic pregnancy;
• Identification of other causes for the discomfort;
• Chronic diseases, except endometriosis, which require continuous pain therapy;
• Previous application of GnRH analogues 6 month prior to study;
• Concurrent use of systemic corticosteroids, antineoplastic agents and/or radiation;
• Planned additional general surgical procedures during the operation for removal of the endometriotic lesions;
• Absence of endometriosis at laparoscopy;
• Partial resection of the bowel or urinary bladder for removal of endometriosis

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 45 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Pius-Hospital Oldenburg

OTHER

Sponsor Role: lead

Responsible Party

Prof. Dr. Dr. med. Rudy Leon De Wilde

Professor Dr. Dr. med.

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Rudy L De Wilde, Professor

Role: PRINCIPAL_INVESTIGATOR

Pius-Hospital Oldenburg, Department of Gynecology, Obstetrics and Gynecological Oncology

Locations

Pius-Hospital, Department of Gynecology, Obstetrics and Gynecological Oncology, Carl von Ossietzky University

Oldenburg, Lower Saxony, Germany

Site Status: RECRUITING

Countries

Germany

Central Contacts

Rudy L De Wilde, Professor

Role: CONTACT

gyn-sekretariat@pius-hospital.de

+49 441 229 1501

Facility Contacts

Rudy L De Wilde, Professor

Role: primary

gyn-sekretariat@pius-hospital.de

+49 441 229 1501

Other Identifiers

PHDW-003

Identifier Type: -

Identifier Source: org_study_id